icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
Simtuzumab, an Antifibrotic Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2) Enzyme, Is Safe and Well Tolerated in Patients With Liver Disease
 
 
  Reported by Jules Levin
EASL 2013 April Amsterdam
 
Andrew H. Talal1,2, Marlene Feron-Rigodon1, Jeannine Madere3, Xiaoru Wu3, G. Mani Subramanian3, Jeffrey D. Bornstein3 1Weill-Cornell Medical College, New York, NY, USA; 2SUNY-Buffalo, Buffalo, NY, USA; 3Gilead Sciences, Inc., Foster City, CA, USA

HIV1.gif

HIV2.gif

HIV3.gif

HIV4.gif

HIV5.gif

HIV6.gif